TheraRadar
← Back
Data updated: Mar 29, 2026

G AND W LABS INC

DermatologyNeurologyImmunology
Generics

G AND W LABS INC is a generic drug manufacturer focused on Dermatology, Neurology, Immunology.

1982
Since
12
Drugs
-
Trials
125
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

NYSTATIN 2026-02-05
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
AMANTADINE HYDROCHLORIDE 2025-12-05
Labeling
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
SELEGILINE HYDROCHLORIDE 2025-09-04
Labeling
CLINDAMYCIN PHOSPHATE 2025-08-22
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 25%
1 drugs
Neurology 25%
1 drugs
Immunology 25%
1 drugs
Gastroenterology 25%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Dermatology, Immunology, Gastroenterology
Eli Lilly big-pharma
Immunology, Neurology, Dermatology
Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology, Neurology
BAUSCH specialty
Dermatology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Gastroenterology, Neurology